Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.
Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.
复制标题
DOI:
10.1172/jci.insight.149446
复制
发表时间:
2021-07-08
期刊:
影响因子:
8
通讯作者:
Bowerman M
中科院分区:
文献类型:
--
作者:
Meijboom KE;Volpato V;Monzón-Sandoval J;Hoolachan JM;Hammond SM;Abendroth F;de Jong OG;Hazell G;Ahlskog N;Wood MJ;Webber C;Bowerman M
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by loss of survival motor neuron (SMN) protein. While SMN restoration therapies are beneficial, they are not a cure. We aimed to identify potentially novel treatments to alleviate muscle pathology combining transcriptomics, proteomics, and perturbational data sets. This revealed potential drug candidates for repurposing in SMA. One of the candidates, harmine, was further investigated in cell and animal models, improving multiple disease phenotypes, including lifespan, weight, and key molecular networks in skeletal muscle. Our work highlights the potential of multiple and parallel data-driven approaches for the development of potentially novel treatments for use in combination with SMN restoration therapies.
登录
查看更多内容
影响因子:
3.7
作者:
Hammond SM;Gogliotti RG;Rao V;Beauvais A;Kothary R;DiDonato CJ
通讯作者:
DiDonato CJ
影响因子:
4.9
作者:
Boyer, Justin G.;Murray, Lyndsay M.;Kothary, Rashmi
通讯作者:
Kothary, Rashmi
影响因子:
11.2
作者:
Bowerman, Melissa;Swoboda, Kathryn J.;Michalski, John-Paul;Wang, Gen-Sheng;Reeks, Courtney;Beauvais, Ariane;Murphy, Kelley;Woulfe, John;Screaton, Robert A.;Scott, Fraser W.;Kothary, Rashmi
通讯作者:
Kothary, Rashmi
DOI:
10.1073/pnas.1605731113
发表时间:
2016-09-27
影响因子:
11.1
作者:
Hammond, Suzan M.;Hazell, Gareth;Wood, Matthew J. A.
通讯作者:
Wood, Matthew J. A.
DOI:
10.1111/j.1476-5381.1959.tb00255.x
发表时间:
1959-01-01
期刊:
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY
影响因子:
--
作者:
AHMED, A;TAYLOR, NRW
通讯作者:
TAYLOR, NRW